Biomarker to distinguish hepatocellular carcinoma from cholangiocarcinoma by serum a disintegrin and metalloprotease 12.
about
Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methodsSuppression of human hepatocellular cancer cell proliferation by Brucea javanica oil-loaded liposomes via induction of apoptosis.Clinical application of percutaneous drainage in treating hepatocellular carcinoma with bile duct tumor thrombus.Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.Predictors for the development of cholangiocarcinoma and hepatocellular carcinoma: in search for the most accurate biomarker.
P2860
Biomarker to distinguish hepatocellular carcinoma from cholangiocarcinoma by serum a disintegrin and metalloprotease 12.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Biomarker to distinguish hepat ...... tegrin and metalloprotease 12.
@en
type
label
Biomarker to distinguish hepat ...... tegrin and metalloprotease 12.
@en
prefLabel
Biomarker to distinguish hepat ...... tegrin and metalloprotease 12.
@en
P2093
P2860
P356
P1476
Biomarker to distinguish hepat ...... tegrin and metalloprotease 12.
@en
P2093
Jureerut Daduang
Sakda Daduang
Temduang Limpaiboon
P2860
P304
P356
10.5114/AOMS.2011.26613
P577
2011-12-30T00:00:00Z